Outlook Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell

25

OTLK
Outlook Therapeutics

Last Price:

5.76

Seasonality Move:

-12.63%

Sell

43

NBY
NovaBay Pharmaceuticals

Last Price:

0.74

Seasonality Move:

-14.63%

Sell

25

Outlook Therapeutics (OTLK) is a Sell

Is Outlook Therapeutics a Buy, Sell or Hold?

The current Outlook Therapeutics [OTLK] share price is $5.75. The Score for OTLK is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
OTLK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

43

NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

The current NovaBay Pharmaceuticals [NBY] share price is $0.72. The Score for NBY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OTLK Stock Price Chart

What is Outlook Therapeutics's stock price today?

The Outlook Therapeutics share price today is $5.75
The current trend is relatively stagnant and OTLK is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

The NovaBay Pharmaceuticals share price today is $0.72
The current trend is relatively stagnant and NBY is experiencing slight selling pressure.

OTLK Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.07	Sell
Relative Strength Index (14 RSI):	53.97	Buy
Chaikin Money Flow:	-24041	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(5.11 - 5.61)	Buy
Bollinger Bands (100):	(5.79 - 8.01)	Sell

NBY Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0	Buy
Relative Strength Index (14 RSI):	59.56	Buy
Chaikin Money Flow:	-107495	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.59 - 0.71)	Buy
Bollinger Bands (100):	(0.31 - 1.91)	Sell

OTLK Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	5.58	Buy
20-day SMA:	5.34	Buy
50-day SMA:	6.11	Sell
200-day SMA:	7.54	Sell
8-day EMA:	5.61	Buy
20-day EMA:	5.55	Buy
50-day EMA:	6	Sell
200-day EMA:	8.18	Sell

NBY Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.62	Buy
20-day SMA:	0.64	Buy
50-day SMA:	0.59	Buy
200-day SMA:	2.71	Sell
8-day EMA:	0.65	Buy
20-day EMA:	0.63	Buy
50-day EMA:	0.74	Sell
200-day EMA:	6.41	Sell

Outlook Therapeutics Earnings Growth & OTLK Earnings Dates

Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $1.39 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.

Outlook Therapeutics Technical Analysis

	Oct 18	Oct 21	Oct 22	Oct 23	Oct 24	Oct 25	Oct 28	Oct 29	Oct 30	Oct 31
	Oct
	18	21	22	23	24	25	28	29	30	31
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

	Oct 18	Oct 21	Oct 22	Oct 23	Oct 24	Oct 25	Oct 28	Oct 29	Oct 30	Oct 31
	Oct
	18	21	22	23	24	25	28	29	30	31
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):